跳至主要内容
临床试验/NCT04667819
NCT04667819Unknown不适用

Clinical Efficacy of Wireless Micropump in Dry Eye Patients

Tianjin Eye Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
20
试验地点
1
主要终点
tear film break-up time

研究概览

简要总结

The purpose of this study is to carry out a trial to get more convincing and valuable results of the wireless micropump in dry eye patients and compare the outcomes before and after eye drops usage. The investigators hope to investigate the micropump comprehensively, including the comparison of tear film break-up time, corneal epithelium defect percentage, and tear film thickness. To meet the demands of a trial, all the examination equipment should be the same for each patient, and this will limit the variations within a study.

详细描述

The purpose of this study is to carry out a trial to get more convincing and valuable results of the wireless micropump in dry eye patients and compare the outcomes before and after eye drops usage. The investigators hope to investigate the micropump comprehensively, including the comparison of tear film break-up time, corneal epithelium defect percentage, and tear film thickness. To meet the demands of a trial, all the examination equipment and methods should be the same for each patient, and this will limit the variations within a study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elimination of serious mental and psychological diseases;
  • be accompanied by a parent or guardian who is able to give informed consent as demonstrated by signing a record of informed consent;
  • be willing to comply with the clinical trial visit schedule as directed by the investigator;
  • at baseline, be within the age range of 18 to 80 years old inclusive;
  • BCVA≥1.0 of both eyes for each patient;
  • dry eye test is BUT<5s and or Schimer test<5mm/5min;
  • without other ophthalmic diseases;

排除标准

  • At the same time, patients with other eye diseases (such as glaucoma, corneal opacity, uveitis, etc.) were diagnosed;
  • serious mental and psychological diseases;
  • history of refractive surgery;
  • nystagmus or failure to cooperate;
  • history of intraocular surgery;
  • patients with systemic diseases (such as diabetes, hypertension, heart disease, etc.)

研究组 & 干预措施

sodium hyaluronate

Experimental

Sodium hyaluronate has become a novel and effective eye drop for the treatment of the dry eye. However, we design a special method of usage of sodium hyaluronate in dry eye patients.

干预措施: Sodium Hyaluronate (Drug)

结局指标

主要结局

tear film break-up time

时间窗: change from baseline with OCCULUS at 6 months

change before and after sodium hyaluronate with OCCULUS

tear film thickness

时间窗: change from baseline with OCCULUS at 6 months

change before and after sodium hyaluronate with OCCULUS

corneal epithelium defect percentage

时间窗: change from baseline with OCCULUS at 6 months

change before and after sodium hyaluronate with OCCULUS

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验